The Global Resource For Connecting Buyers and Sellers

CSA Medical Announces the Completion of Treatments in the RejuvenAir Safety and Feasibility Study for patients with Chronic Bronchitis

LEXINGTON, Mass., March 1, 2018 /PRNewswire/ — CSA Medical, Inc. announced the completion of the treatment phase for its ongoing study The Safety and Feasibility Study of RejuvenAir for Treating Chronic Bronchitis Patients (NCT02483637).  This prospective, open label, single arm study of…